Cargando…
Clinical Research Progress of Small Molecule Compounds Targeting Nrf2 for Treating Inflammation-Related Diseases
Studies have found that inflammation is a symptom of various diseases, such as coronavirus disease 2019 (COVID-19) and rheumatoid arthritis (RA); it is also the source of other diseases, such as Alzheimer’s disease (AD), Parkinson’s disease (PD), lupus erythematosus (LE), and liver damage. Nrf2 (nuc...
Autores principales: | Zhai, Zhenzhen, Huang, Yanxin, Zhang, Yawei, Zhao, Lili, Li, Wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405369/ https://www.ncbi.nlm.nih.gov/pubmed/36009283 http://dx.doi.org/10.3390/antiox11081564 |
Ejemplares similares
-
Research Progress of Natural Small-Molecule Compounds Related to Tumor Differentiation
por: He, Xiaoli, et al.
Publicado: (2022) -
Research Progress on Natural Small-Molecule Compounds for the Prevention and Treatment of Sepsis
por: Su, Jingqian, et al.
Publicado: (2023) -
Role of Small Molecule Targeted Compounds in Cancer: Progress, Opportunities, and Challenges
por: Sun, Guoqiang, et al.
Publicado: (2021) -
Small molecule compounds targeting the p53 pathway: are we finally making progress?
por: Yu, Xin, et al.
Publicado: (2014) -
A small molecule NRF2 activator BC-1901S ameliorates inflammation through DCAF1/NRF2 axis
por: Chen, Yanwen, et al.
Publicado: (2020)